Table 1 Demographic and clinical data of patients and control
From: GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
Group I (Cases) N = 60 | Group II (Control) N = 28 | p value | ||
|---|---|---|---|---|
Age (years) | Median(IQR) | 10.0 (8.0 – 13.0) | 12.0 (10.3 – 13.0) | 0.049* |
Males | 36 (60.0%) | 11 (39.3%) | 0.07 | |
Females | N% | 24 (40.0%) | 17 (60.7%) | |
Rural | 46 (76.7%) | 19 (67.9%) | 0.381 | |
Urban | N% | 14 (23.3%) | 9 (32.1%) | |
Weight (kg) | Median(IQR) | 29.0 (23.0 – 35.5) | 33.0 (30.0 – 35.8) | 0.02* |
Height (cm) | Median(IQR) | 136.0 (122.3 – 144.0) | 144.0 (135.8 – 148.0) | 0.003* |
BMI (kg/m2) | Median(IQR) | 16.0 (14.5 – 18.4) | 15.8 (15.2 – 17.5) | 0.964 |